Matches in Nanopublications for { ?s ?p "[The aggregate frequency of CHD5 haploinsufficiency or inactivation is 16.2% in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_assertion description "[The aggregate frequency of CHD5 haploinsufficiency or inactivation is 16.2% in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_provenance.
- NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_assertion description "[The aggregate frequency of CHD5 haploinsufficiency or inactivation is 16.2% in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_provenance.
- NP788254.RA_YprDIllSwl05vVrSgoO8Oyi8tM77xRFD6kaYfGlrhI130_assertion description "[The aggregate frequency of CHD5 haploinsufficiency or inactivation is 16.2% in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788254.RA_YprDIllSwl05vVrSgoO8Oyi8tM77xRFD6kaYfGlrhI130_provenance.